PH-797804: Clinical Trials

6 trials of PH-797804, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Completed 5, Withdrawn 1

Follow PH-797804: new trials by email Literature Review of PH-797804 trials Research Report on PH-797804

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804
PH-797804 - Healthy
Phase 1WithdrawnPfizer2014-03-012013-12-20
A Study to Investigate the Effect of PH-797804 on QTc Interval
PH-797804, Moxifloxacin, Placebo - Healthy
Phase 1CompletedPfizer482013-04-012013-08-15
A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804
PH-797804, PH-797804 + erythromycin - Healthy
Phase 1CompletedPfizer122012-06-012012-08-17
A Study To Investigate The Effect Of Food On The Pharmacokinetics Of PH-797804
PH-797804 - Healthy Volunteers
Phase 1CompletedPfizer282011-12-012012-02-28
Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers
PF-03715455, PH-797804, Placebo for PF-03715455 - Chronic Obstructive Pulmonary Disease (COPD)
Phase 1CompletedPfizer392011-01-012012-02-02
PH-797804 LPS Study in Healthy Volunteers
PH-797804, Placebo - Healthy
Phase 1CompletedPfizer242006-09-012014-03-14

Conditions studied

Pulmonary Disease, Chronic Obstructive (2)

Sponsors

Pfizer (6)

Countries

Singapore (2)  ·  United Kingdom (2)  ·  United States (1)